• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度肝硬化和血清HBeAg转阴并不意味着乙肝相关肝硬化患者发生肝细胞癌的风险较低。

Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.

作者信息

Xu Jing, Shi Jian, Wang Yi-Ping, Lin Yong, Chen Yue-Xiang, Lu Jian, Zeng Xin, Xie Wei-Fen

机构信息

Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China.

出版信息

Med Sci Monit. 2009 Jun;15(6):CR274-9.

PMID:19478697
Abstract

BACKGROUND

Serum HBeAg status and liver cirrhosis severity at the time of diagnosis of hepatocellular carcinoma (HCC) in hepatitis B virus (HBV)-related cirrhosis remain inconclusive. The aim was to investigate the status of HBeAg and cirrhosis severity at the time of HCC development in the natural history of HBV-related cirrhosis in mainland China.

MATERIAL/METHODS: In a retrospective cross-sectional hospital-based setting, HBeAg status and severity of underlying cirrhosis, estimated by MELD (model for end-stage liver disease) scores and aspartate aminotransferase (AST)--to-platelet ratio index (APRI), were comprehensively compared in 377 HBsAg-positive compensated and decompensated liver cirrhosis and 434 with HCC patients to clarify the independent and joint effects of the factors.

RESULTS

The majority (80.6%) of the HCC patients was negative for serum HBeAg. More than two-thirds of the patients with HCC had MELD scores <10. Severity of underlying liver cirrhosis and loss of serum HBeAg independently correlated with the risk of HCC development. Compared with the contrast group of HBeAg-positive patients with MELD scores > or =20, the odds ratio of HCC development in the patients with HBeAg negativity and MELD score <10 was 26.51 (95%CI: 8.98-78.28).

CONCLUSIONS

A large proportion of HBV-related cirrhotic patients had negative serum HBeAg and mild cirrhosis severity at the time of diagnosis of HCC.

摘要

背景

在乙型肝炎病毒(HBV)相关肝硬化患者中,肝细胞癌(HCC)诊断时血清HBeAg状态和肝硬化严重程度仍无定论。本研究旨在探讨中国大陆HBV相关肝硬化自然史中HCC发生时HBeAg状态及肝硬化严重程度。

材料/方法:在一项基于医院的回顾性横断面研究中,对377例HBsAg阳性的代偿期和失代偿期肝硬化患者及434例HCC患者的HBeAg状态和潜在肝硬化的严重程度进行了综合比较,潜在肝硬化严重程度通过终末期肝病模型(MELD)评分和天冬氨酸氨基转移酶(AST)-血小板比值指数(APRI)评估,以明确各因素的独立及联合作用。

结果

大多数(80.6%)HCC患者血清HBeAg阴性。超过三分之二的HCC患者MELD评分<10。潜在肝硬化的严重程度和血清HBeAg阴性与HCC发生风险独立相关。与MELD评分≥20的HBeAg阳性患者对照组相比,HBeAg阴性且MELD评分<10的患者发生HCC的比值比为26.51(95%CI:8.98-78.28)。

结论

很大一部分HBV相关肝硬化患者在HCC诊断时血清HBeAg阴性且肝硬化严重程度较轻。

相似文献

1
Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.轻度肝硬化和血清HBeAg转阴并不意味着乙肝相关肝硬化患者发生肝细胞癌的风险较低。
Med Sci Monit. 2009 Jun;15(6):CR274-9.
2
Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.隐匿性乙型肝炎病毒感染和既往乙型肝炎病毒感染对丙型肝炎病毒所致肝硬化患者肝细胞癌发生的影响
Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.
3
Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.血清乙肝e抗原阳性与乙肝相关肝细胞癌根治性切除术后患者早期复发风险较高及生存率较低相关。
J Hepatol. 2007 Nov;47(5):684-90. doi: 10.1016/j.jhep.2007.06.019. Epub 2007 Aug 13.
4
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.乙型和丙型肝炎病毒感染对代偿期肝硬化自然史的影响:一项对297例患者的队列研究。
Am J Gastroenterol. 2002 Nov;97(11):2886-95. doi: 10.1111/j.1572-0241.2002.07057.x.
5
[The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].[根据酒精和乙型肝炎病毒病因分析肝硬化合并肝细胞癌患者的Child-Pugh评分、PGA指数与MELD评分的相关性]
Taehan Kan Hakhoe Chi. 2003 Jun;9(2):107-15.
6
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.丙型肝炎病毒相关肝硬化患者血清抗-HBc可检测性与肝细胞癌之间缺乏相关性。
Am J Gastroenterol. 2008 Aug;103(8):1966-72. doi: 10.1111/j.1572-0241.2008.01912.x. Epub 2008 Jul 12.
7
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析:一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.
8
Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.乙型肝炎病毒基础核心启动子突变与HBeAg阴性慢性乙型肝炎的肝病进展
Liver Int. 2005 Jun;25(3):564-70. doi: 10.1111/j.1478-3231.2005.01041.x.
9
Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.与肝炎病毒相关肝硬化患者肝细胞癌发生相关的临床和病理因素:一项长期随访研究
Clin Oncol (R Coll Radiol). 2007 Apr;19(3):197-203. doi: 10.1016/j.clon.2006.12.005. Epub 2007 Jan 18.
10
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.抗病毒治疗不能预防拉米夫定单药起始治疗的 HBeAg 阴性代偿期乙型肝炎肝硬化患者发生肝癌:全国性 HEPNET. 希腊队列研究结果。
Gut. 2011 Aug;60(8):1109-16. doi: 10.1136/gut.2010.221846. Epub 2011 Jan 26.

引用本文的文献

1
Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?伴有潜在肝硬化的乙型肝炎病毒相关肝细胞癌中的血管侵犯:与腹水及乙型肝炎病毒因素的可能关联?
Tumour Biol. 2015 Aug;36(8):6255-63. doi: 10.1007/s13277-015-3311-8. Epub 2015 Apr 2.
2
Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis.天门冬氨酸氨基转移酶-血小板比值指数对乙型肝炎相关纤维化预测的诊断准确性:一项主要的荟萃分析。
BMC Gastroenterol. 2012 Feb 14;12:14. doi: 10.1186/1471-230X-12-14.
3
Alterations in the erythrocyte plasma membranes in patients with alcohol-induced liver cirrhosis - preliminary results.
酒精性肝硬化患者红细胞血浆膜的改变——初步结果。
Arch Med Sci. 2011 Feb;7(1):87-91. doi: 10.5114/aoms.2011.20609. Epub 2011 Mar 8.
4
Transarterial Chemoembolization of Child-A hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin/lipiodol (cTACE).儿童肝细胞癌的经动脉化疗栓塞术:载药微球化疗栓塞术(DEB-TACE)对比顺铂/碘油(cTACE)化疗栓塞术。
Med Sci Monit. 2011 Apr;17(4):CR189-95. doi: 10.12659/msm.881714.
5
The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area.与丙型肝炎感染相关的肝细胞癌在九州地区的发病率下降。
Med Sci Monit. 2011 Feb;17(2):PH7-11. doi: 10.12659/msm.881375.
6
Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.肝硬化存在于大多数乙型肝炎和肝细胞癌患者中。
Clin Gastroenterol Hepatol. 2011 Jan;9(1):64-70. doi: 10.1016/j.cgh.2010.08.019. Epub 2010 Sep 8.